News articles about HCP (NYSE:HCP) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. HCP earned a coverage optimism score of 0.18 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 46.9284124451794 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

Shares of HCP (NYSE:HCP) remained flat at $$26.80 during trading on Tuesday. 3,212,500 shares of the stock traded hands, compared to its average volume of 3,714,316. The stock has a market cap of $12,550.00, a PE ratio of 13.01, a price-to-earnings-growth ratio of 2.86 and a beta of 0.31. The company has a debt-to-equity ratio of 1.17, a current ratio of 0.61 and a quick ratio of 0.61. HCP has a 52-week low of $25.08 and a 52-week high of $33.67.

HCP (NYSE:HCP) last issued its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.02. The firm had revenue of $454.00 million during the quarter, compared to analyst estimates of $440.60 million. HCP had a return on equity of 8.85% and a net margin of 27.31%. The business’s quarterly revenue was down 14.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.72 earnings per share. equities research analysts expect that HCP will post 1.94 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 21st. Stockholders of record on Monday, November 6th will be given a dividend of $0.37 per share. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.52%. HCP’s payout ratio is 264.29%.

Several research firms have recently weighed in on HCP. Goldman Sachs Group, Inc. (The) cut HCP from a “buy” rating to a “neutral” rating and lowered their price target for the company from $35.00 to $32.00 in a report on Monday, July 24th. Zacks Investment Research raised HCP from a “sell” rating to a “hold” rating in a report on Thursday, November 9th. BidaskClub cut HCP from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Mizuho raised HCP from a “neutral” rating to a “buy” rating and set a $32.00 price target on the stock in a report on Thursday, November 2nd. Finally, KeyCorp reissued a “hold” rating on shares of HCP in a report on Sunday, September 17th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. HCP has a consensus rating of “Hold” and an average target price of $30.91.

ILLEGAL ACTIVITY NOTICE: “HCP (HCP) Receives Daily Media Impact Score of 0.18” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Insider Buying and Selling by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.